Weng Y, Xue S N, Zhang S L, Cheng H, Yan L
Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
Zhonghua Nei Ke Za Zhi. 2018 Feb 1;57(2):134-137. doi: 10.3760/cma.j.issn.0578-1426.2018.02.010.
Multiple endocrine neoplasia type 2A (MEN2A) is a hereditary syndrome. Here, two different RET proto-oncogen mutation were identified from family members of two MEN2A pedigrees by genetic screening. One RET mutations were found at codons 1893 and 1895 in exon 11 (1893-1895delCGA) from pedigree 1, which is a novel mutation, the other occurs at codon 634 (Cys634Arg) in exon 11 from pedigree 2. However, the clinical characteristics were similar in the patients of the two pedigrees. All the patients were in middle-age at onset. Most of them were firstly diagnosed with bilateral adrenal pheochromocytoma with different degrees of thyroid abnormalities (elevated serum calcitonin with or without thyroid mass, or had been diagnosed with medullary thyroid carcinoma). Some family members were with elevated serum parathyroid hormone but with no other evidences for hyperparathyroidism.
2A型多发性内分泌腺瘤病(MEN2A)是一种遗传性综合征。在此,通过基因筛查从两个MEN2A家系的家庭成员中鉴定出两种不同的RET原癌基因突变。在谱系1的第11外显子的密码子1893和1895处发现了一种RET突变(1893 - 1895delCGA),这是一种新突变,另一种发生在谱系2的第11外显子的密码子634(Cys634Arg)处。然而,两个家系患者的临床特征相似。所有患者发病时均为中年。他们中的大多数首先被诊断为双侧肾上腺嗜铬细胞瘤,并伴有不同程度的甲状腺异常(血清降钙素升高,伴有或不伴有甲状腺肿块,或已被诊断为甲状腺髓样癌)。一些家庭成员血清甲状旁腺激素升高,但无其他甲状旁腺功能亢进的证据。